Back to Search Start Over

How to manage cigarette smoking in kidney transplant candidates and recipients?

Authors :
Arnaud Devresse
Arnaud Robert
Nada Kanaan
Sophie Gohy
UCL - SSS/IREC/NEFR - Pôle de Néphrologie
UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie
UCL - (SLuc) Service de pneumologie
UCL - (SLuc) Service de néphrologie
UCL - (SLuc) Centre de référence pour la mucoviscidose
Source :
Clinical kidney journal, Vol. 14, no. 10, p. 2295-2303 (2021), Clinical Kidney Journal
Publication Year :
2021
Publisher :
Oxford University Press (OUP), 2021.

Abstract

Tobacco smoking is a frequent problem affecting many kidney transplant (KT) candidates and recipients. The negative impact of active smoking on KT outcomes has been demonstrated. Consequently, most guidelines strongly recommend quitting smoking before considering kidney transplantation. However, nicotine addiction is a complex multifactorial disease and only 3–5% of the patients who try to quit by themselves achieve prolonged abstinence. Smoking cessation programmes (SCPs) have proven their efficacy in the general population to increase the rate of quitting and should therefore be proposed to all smoking KT candidates and recipients. Nevertheless, SCPs have not been evaluated in the KT field and not all KT centres have easy access to these programmes. In this work, we aim to review the current knowledge on the subject and provide an overview of the available interventions to help smoking patients quit. We detail non-pharmaceutical and pharmaceutical approaches and discuss their use in KT candidates and recipients.

Details

Language :
English
Database :
OpenAIRE
Journal :
Clinical kidney journal, Vol. 14, no. 10, p. 2295-2303 (2021), Clinical Kidney Journal
Accession number :
edsair.doi.dedup.....0850719eb1c573a5881a3a3ff954b88d